<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02896387</url>
  </required_header>
  <id_info>
    <org_study_id>EGN_2016_14</org_study_id>
    <nct_id>NCT02896387</nct_id>
  </id_info>
  <brief_title>Ability of a Molecule (Prima) to Restore Physiological Differentiation in Epithelium Expressing Gene p63</brief_title>
  <acronym>PRIMAculture</acronym>
  <official_title>Ex Vivo and in Vitro Assessment of the Pharmacological Properties of Molecule Prima in the Restoration of Physiological Differentiation of Gene p63 Dependant Epithelium</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fondation Ophtalmologique Adolphe de Rothschild</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Institut National de la Santé Et de la Recherche Médicale, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Fondation Ophtalmologique Adolphe de Rothschild</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Ectodermal dysplasia associated with p63 is a rare disease which, in addition to limbic&#xD;
      abnormalities, primarily affects the skin and cornea. The most common forms are called&#xD;
      Ectrodactyly, Ectodermal dysplasia, palate Key for cleft lip and palate (EEC) and&#xD;
      Ankyloblepharon, Ectodermal dysplasia, cleft lip and palate (AEC). Apart from symptomatic&#xD;
      treatment, no cure is available. To understand the molecular defects associated with this&#xD;
      disease and to identify therapeutic tools, a research team modelized the disease by&#xD;
      reprograming EEC and AEC patient fibroblasts in pluripotent stem cells (iPSC), then induced&#xD;
      iPSC differentiation in patients and controls epidermal (skin) and limbic (cornea) cells and&#xD;
      demonstrated that the mutated cells can reproduce in vitro the abnormalities observed in&#xD;
      patients.&#xD;
&#xD;
      P63 gene belongs to the family of p53 gene. The functions of the two proteins are very&#xD;
      similar. Data suggest that molecule Prima could reactivate the p63 protein mutated in&#xD;
      patients and thus alleviate skin defect healing and limbic regeneration.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Suspended</overall_status>
  <why_stopped>
    Laboratory change, stem cell circuit on standby&#xD;
  </why_stopped>
  <start_date type="Actual">March 3, 2017</start_date>
  <completion_date type="Anticipated">March 2022</completion_date>
  <primary_completion_date type="Anticipated">March 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>the differentiation of corneal epithelium by histological observation</measure>
    <time_frame>baseline</time_frame>
    <description>the differentiation of corneal epithelium by histological observation</description>
  </primary_outcome>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Ectodermal Dysplasia</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patient with genetic pathology of the ocular surface&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient with genetic pathology of the ocular surface&#xD;
&#xD;
          -  Age ≥ 7 years&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Agonal glaucoma&#xD;
&#xD;
          -  low vision mostly related to retinal pathology&#xD;
&#xD;
          -  Pregnant or breast-feeding patient&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>7 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eric GABISON</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fondation ophtalmologique de Rothschild</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Fondation Opthalmologique A de Rothschild</name>
      <address>
        <city>Paris</city>
        <zip>75019</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hopital Necker</name>
      <address>
        <city>Paris</city>
        <zip>75019</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>August 29, 2016</study_first_submitted>
  <study_first_submitted_qc>September 6, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 12, 2016</study_first_posted>
  <last_update_submitted>April 8, 2021</last_update_submitted>
  <last_update_submitted_qc>April 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ectodermal Dysplasia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

